AVR Anteris Technologies (ASX: AVR) is set to transform the heart valve repair market with its ADAPT® technology—a $7.5 billion industry.
💥 Why it’s poised for massive growth:
Revolutionary tech for heart health.
Key partnerships in healthcare.
Institutional accumulation driving up value.
🚀 Prediction: $200+ by 2026, potentially reaching $1,000+ long-term.
💬 Get real-time updates on Telegram: (i. v. a. n. p. a. t. r. i. c. e)